Gregory Carven
Gregory Carven is a key researcher and inventor associated with the development of pembrolizumab, the active ingredient in the cancer treatment Keytruda. Initially focused on autoimmune diseases, his team pivoted to cancer therapy upon discovering the drug's potential to enhance immune responses against tumors.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Gregory Carven was one of the inventors of the drug pembrolizumab at Organon.
6